2-48755616-GGCTGCA-GGCTGCAGCTGCAGCAGCAGCAGCAGCTTCAGCAGCTGCA

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PP5_ModerateBP3

The NM_000233.4(LHCGR):​c.55_56insTGCTGAAGCTGCTGCTGCTGCTGCAGCTGCAGC​(p.Gln18_Pro19insLeuLeuLysLeuLeuLeuLeuLeuGlnLeuGln) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000352 in 1,532,406 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Pathogenic (★).

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 25)
Exomes 𝑓: 0.000033 ( 0 hom. )

Consequence

LHCGR
NM_000233.4 conservative_inframe_insertion

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 0.0830

Publications

2 publications found
Variant links:
Genes affected
LHCGR (HGNC:6585): (luteinizing hormone/choriogonadotropin receptor) This gene encodes the receptor for both luteinizing hormone and choriogonadotropin. This receptor belongs to the G-protein coupled receptor 1 family, and its activity is mediated by G proteins which activate adenylate cyclase. Mutations in this gene result in disorders of male secondary sexual character development, including familial male precocious puberty, also known as testotoxicosis, hypogonadotropic hypogonadism, Leydig cell adenoma with precocious puberty, and male pseudohermaphtoditism with Leydig cell hypoplasia. [provided by RefSeq, Jul 2008]
STON1-GTF2A1L (HGNC:30651): (STON1-GTF2A1L readthrough) STON1-GTF2A1L mRNAs are infrequent but naturally occurring read-through products of the neighboring STON1 and GTF2A1L genes. These transcripts encode fusion proteins composed of the vast majority of each of the individual elements, stonin 1 and general transcription factor IIA, 1-like. Alternative splicing results in multiple transcript variants. The significance of these read-through variants and the function of the resulting protein products have not yet been determined. [provided by RefSeq, Oct 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PP5
Variant 2-48755616-G-GGCTGCAGCTGCAGCAGCAGCAGCAGCTTCAGCA is Pathogenic according to our data. Variant chr2-48755616-G-GGCTGCAGCTGCAGCAGCAGCAGCAGCTTCAGCA is described in ClinVar as Pathogenic. ClinVar VariationId is 14405.Status of the report is criteria_provided_single_submitter, 1 stars.
BP3
Nonframeshift variant in repetitive region in NM_000233.4

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LHCGRNM_000233.4 linkc.55_56insTGCTGAAGCTGCTGCTGCTGCTGCAGCTGCAGC p.Gln18_Pro19insLeuLeuLysLeuLeuLeuLeuLeuGlnLeuGln conservative_inframe_insertion Exon 1 of 11 ENST00000294954.12 NP_000224.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LHCGRENST00000294954.12 linkc.55_56insTGCTGAAGCTGCTGCTGCTGCTGCAGCTGCAGC p.Gln18_Pro19insLeuLeuLysLeuLeuLeuLeuLeuGlnLeuGln conservative_inframe_insertion Exon 1 of 11 1 NM_000233.4 ENSP00000294954.6
ENSG00000279956ENST00000602369.3 linkn.55_56insTGCTGAAGCTGCTGCTGCTGCTGCAGCTGCAGC non_coding_transcript_exon_variant Exon 1 of 13 5 ENSP00000473498.1

Frequencies

GnomAD3 genomes
AF:
0.0000527
AC:
8
AN:
151850
Hom.:
0
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000295
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000151
AC:
2
AN:
132330
AF XY:
0.0000138
show subpopulations
Gnomad AFR exome
AF:
0.000162
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000248
GnomAD4 exome
AF:
0.0000333
AC:
46
AN:
1380556
Hom.:
0
Cov.:
34
AF XY:
0.0000279
AC XY:
19
AN XY:
681126
show subpopulations
African (AFR)
AF:
0.0000636
AC:
2
AN:
31426
American (AMR)
AF:
0.00
AC:
0
AN:
35580
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25012
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35686
South Asian (SAS)
AF:
0.0000127
AC:
1
AN:
78996
European-Finnish (FIN)
AF:
0.0000269
AC:
1
AN:
37214
Middle Eastern (MID)
AF:
0.000247
AC:
1
AN:
4054
European-Non Finnish (NFE)
AF:
0.0000363
AC:
39
AN:
1075066
Other (OTH)
AF:
0.0000348
AC:
2
AN:
57522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000527
AC:
8
AN:
151850
Hom.:
0
Cov.:
25
AF XY:
0.0000404
AC XY:
3
AN XY:
74188
show subpopulations
African (AFR)
AF:
0.000145
AC:
6
AN:
41352
American (AMR)
AF:
0.00
AC:
0
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000295
AC:
2
AN:
67844
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000481
Hom.:
446

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Pathogenic:1
Aug 04, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects LHCGR function (PMID: 9817592). This variant is also known as insLLKLLLLLQ[LQ]. This variant has been observed in individual(s) with autosomal recessive 46, XY leydig cell hypoplasia (PMID: 9817592, 11849253). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is present in population databases (no rsID available, gnomAD 0.02%). This variant, c.55_56ins33, results in the insertion of 11 amino acid(s) of the LHCGR protein (p.Gln18_Pro19ins11), but otherwise preserves the integrity of the reading frame.

Leydig cell agenesis Pathogenic:1
Nov 01, 1998
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.083
Mutation Taster
=87/13
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71245621; hg19: chr2-48982755; API